Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 1, Issue 1
June 2018
Issue Cover
All Issues
EISSN 2504-3889

Medical Cannabis and Cannabinoids 2018, Vol. 1, No. 1

Editorial

Editorial
Rudolf Brenneisen
Med Cannabis Cannabinoids (2018) 1 (1): 1–2. https://doi.org/10.1159/000489029
View articletitled, Editorial
Open the PDF for in another window

Interview

Walter Zieglgänsberger
Walter Zieglgänsberger
Med Cannabis Cannabinoids (2018) 1 (1): 3. https://doi.org/10.1159/000489475
View articletitled, Walter Zieglgänsberger
Open the PDF for in another window
Barbara Broers
Barbara Broers
Med Cannabis Cannabinoids (2018) 1 (1): 4. https://doi.org/10.1159/000489052
View articletitled, Barbara Broers
Open the PDF for in another window
Franjo Grotenhermen
Franjo Grotenhermen
Med Cannabis Cannabinoids (2018) 1 (1): 5. https://doi.org/10.1159/000489141
View articletitled, Franjo Grotenhermen
Open the PDF for in another window
Arno Hazekamp
Arno Hazekamp
Med Cannabis Cannabinoids (2018) 1 (1): 6. https://doi.org/10.1159/000489363
View articletitled, Arno Hazekamp
Open the PDF for in another window
Kirsten R. Müller-Vahl
Kirsten R. Müller-Vahl
Med Cannabis Cannabinoids (2018) 1 (1): 7. https://doi.org/10.1159/000489140
View articletitled, Kirsten R. Müller-Vahl
Open the PDF for in another window
Shogo Tokuyama
Shogo Tokuyama
Med Cannabis Cannabinoids (2018) 1 (1): 8. https://doi.org/10.1159/000489139
View articletitled, Shogo Tokuyama
Open the PDF for in another window

Basic Science - Research Article

Determination of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol with Gas Chromatography-Mass Spectrometry: Analytical and Preanalytical Challenges and Pitfalls
Christian Lanz; Johan Mattsson; Felix Stickel; Jean-Francois Dufour; Rudolf Brenneisen
Med Cannabis Cannabinoids (2018) 1 (1): 9–18. https://doi.org/10.1159/000489032
View articletitled, Determination of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol with Gas Chromatography-Mass Spectrometry: Analytical and Preanalytical Challenges and Pitfalls
Open the PDF for in another window
The Effect of Light Spectrum on the Morphology and Cannabinoid Content of Cannabis sativa L.
Gianmaria Magagnini; Gianpaolo Grassi; Stiina Kotiranta
Med Cannabis Cannabinoids (2018) 1 (1): 19–27. https://doi.org/10.1159/000489030
View articletitled, The Effect of Light Spectrum on the Morphology and Cannabinoid Content of Cannabis sativa L.
Open the PDF for in another window

Preclinical Science and Clinical Studies - Review

Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon?
Magdalena Grill; Carina Hasenoehrl; Martin Storr; Rudolf Schicho
Med Cannabis Cannabinoids (2018) 1 (1): 28–35. https://doi.org/10.1159/000489036
View articletitled, Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon?
Open the PDF for in another window

Preclinical Science and Clinical Studies - Research Article

Human Pharmacokinetics and Adverse Effects of Pulmonary and Intravenous THC-CBD Formulations
Pascale Meyer; Manuela Langos; Rudolf Brenneisen
Med Cannabis Cannabinoids (2018) 1 (1): 36–43. https://doi.org/10.1159/000489034
View articletitled, Human Pharmacokinetics and Adverse Effects of Pulmonary and Intravenous THC-CBD Formulations
Open the PDF for in another window
Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC
Mahmoud A. ElSohly; Waseem Gul; Larry A. Walker
Med Cannabis Cannabinoids (2018) 1 (1): 44–53. https://doi.org/10.1159/000489037
View articletitled, Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC
Open the PDF for in another window
Effects of Cannabidiol and a Novel Cannabidiol Analog against Tactile Allodynia in a Murine Model of Cisplatin-Induced Neuropathy: Enhanced Effects of Sub-Analgesic Doses of Morphine
Hannah Marie Harris; Waseem Gul; Mahmoud A. ElSohly; Kenneth J. Sufka
Med Cannabis Cannabinoids (2018) 1 (1): 54–59. https://doi.org/10.1159/000489077
View articletitled, Effects of Cannabidiol and a Novel Cannabidiol Analog against Tactile Allodynia in a Murine Model of Cisplatin-Induced Neuropathy: Enhanced Effects of Sub-Analgesic Doses of Morphine
Open the PDF for in another window

Preclinical Science and Clinical Studies - Commentary

The Intricate Influence of the Placebo Effect on Medical Cannabis and Cannabinoids
Jürg Gertsch
Med Cannabis Cannabinoids (2018) 1 (1): 60–64. https://doi.org/10.1159/000489291
View articletitled, The Intricate Influence of the Placebo Effect on Medical Cannabis and Cannabinoids
Open the PDF for in another window

Legal and Regulatory Aspects - Commentary

The Trouble with CBD Oil
Arno Hazekamp
Med Cannabis Cannabinoids (2018) 1 (1): 65–72. https://doi.org/10.1159/000489287
View articletitled, The Trouble with CBD Oil
Open the PDF for in another window
Development and in vitro Evaluation of Cannabidiol Mucoadhesive Buccal Film Formulations Using Hot-Melt Extrusion Technology
Cannabinoids for the treatment of glaucoma: a review
Use of cannabidiol-dominant extract as co-adjuvant therapy for type 2 diabetes mellitus treatment in feline: case report
Long-term treatment for unspecified anxiety disorders with cannabidiol (CBD): A retrospective case series from real-world evidence (RWE) in Colombia
  • Online ISSN 2504-3889
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal